Back to 
Cresset Asset Management, LLC
Cresset Asset Management, LLC
CLDX
Showing 0 of 10 quarters
Position history for Cresset Asset Management, LLC's holdings in Celldex Therapeutics, Inc.
No. Cresset Asset Management exited its CLDX (Celldex Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 457,666 shares worth $15.3M. Cresset Asset Management first reported CLDX in Q2 2019 and held it in 9 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.